BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 9445037)

  • 1. An ATF/CRE element mediates both EBNA2-dependent and EBNA2-independent activation of the Epstein-Barr virus LMP1 gene promoter.
    Sjöblom A; Yang W; Palmqvist L; Jansson A; Rymo L
    J Virol; 1998 Feb; 72(2):1365-76. PubMed ID: 9445037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PU box-binding transcription factors and a POU domain protein cooperate in the Epstein-Barr virus (EBV) nuclear antigen 2-induced transactivation of the EBV latent membrane protein 1 promoter.
    Sjöblom A; Jansson A; Yang W; Laín S; Nilsson T; Rymo L
    J Gen Virol; 1995 Nov; 76 ( Pt 11)():2679-92. PubMed ID: 7595375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of a consensus AP-2 regulatory sequence within the Epstein-Barr virus LMP1 promoter in EBNA2 mediated transactivation.
    Jansson A; Johansson P; Yang W; Palmqvist L; Sjöblom-Hallén A; Rymo L
    Virus Genes; 2007 Oct; 35(2):203-14. PubMed ID: 17546492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of the LMP1 gene promoter in Epstein-Barr virus-transformed cell lines is modulated by sequence variations in the promoter-proximal CRE site.
    Jansson A; Johansson P; Li S; Rymo L
    J Gen Virol; 2007 Jul; 88(Pt 7):1887-1894. PubMed ID: 17554019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon regulatory factor 7 regulates expression of Epstein-Barr virus latent membrane protein 1: a regulatory circuit.
    Ning S; Hahn AM; Huye LE; Pagano JS
    J Virol; 2003 Sep; 77(17):9359-68. PubMed ID: 12915551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Domains of the Epstein-Barr virus nuclear antigen 2 (EBNA2) involved in the transactivation of the latent membrane protein 1 and the EBNA Cp promoters.
    Sjöblom A; Nerstedt A; Jansson A; Rymo L
    J Gen Virol; 1995 Nov; 76 ( Pt 11)():2669-78. PubMed ID: 7595374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a novel DNA regulatory element in the rabbit surfactant protein B (SP-B) promoter that is a target for ATF/CREB and AP-1 transcription factors.
    Berhane K; Boggaram V
    Gene; 2001 May; 268(1-2):141-51. PubMed ID: 11368910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The NP9 protein encoded by the human endogenous retrovirus HERV-K(HML-2) negatively regulates gene activation of the Epstein-Barr virus nuclear antigen 2 (EBNA2).
    Gross H; Barth S; Pfuhl T; Willnecker V; Spurk A; Gurtsevitch V; Sauter M; Hu B; Noessner E; Mueller-Lantzsch N; Kremmer E; Grässer FA
    Int J Cancer; 2011 Sep; 129(5):1105-15. PubMed ID: 21710493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of an Epstein-Barr virus nuclear antigen 2-responsive cis element in the bidirectional promoter region of latent membrane protein and terminal protein 2 genes.
    Laux G; Dugrillon F; Eckert C; Adam B; Zimber-Strobl U; Bornkamm GW
    J Virol; 1994 Nov; 68(11):6947-58. PubMed ID: 7933076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of the Epstein-Barr virus C promoter by AUF1 and the cyclic AMP/protein kinase A signaling pathway.
    Fuentes-Pananá EM; Peng R; Brewer G; Tan J; Ling PD
    J Virol; 2000 Sep; 74(17):8166-75. PubMed ID: 10933728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Counteracting effects of cellular Notch and Epstein-Barr virus EBNA2: implications for stromal effects on virus-host interactions.
    Rowe M; Raithatha S; Shannon-Lowe C
    J Virol; 2014 Oct; 88(20):12065-76. PubMed ID: 25122803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response to cAMP levels of the Epstein-Barr virus EBNA2-inducible LMP1 oncogene and EBNA2 inhibition of a PP1-like activity.
    Fåhraeus R; Palmqvist L; Nerdstedt A; Farzad S; Rymo L; Laín S
    EMBO J; 1994 Dec; 13(24):6041-51. PubMed ID: 7813442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ATF/CREB elements in the herpes simplex virus type 1 latency-associated transcript promoter interact with members of the ATF/CREB and AP-1 transcription factor families.
    Millhouse S; Kenny JJ; Quinn PG; Lee V; Wigdahl B
    J Biomed Sci; 1998; 5(6):451-64. PubMed ID: 9845850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Epstein-Barr virus nuclear antigen 2 interacts with an EBNA2 responsive cis-element of the terminal protein 1 gene promoter.
    Zimber-Strobl U; Kremmer E; Grässer F; Marschall G; Laux G; Bornkamm GW
    EMBO J; 1993 Jan; 12(1):167-75. PubMed ID: 8381349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Definition of the transcription factors which bind the differentiation responsive element of the Epstein-Barr virus BZLF1 Z promoter in human epithelial cells.
    MacCallum P; Karimi L; Nicholson LJ
    J Gen Virol; 1999 Jun; 80 ( Pt 6)():1501-1512. PubMed ID: 10374969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional cooperation of Epstein-Barr virus nuclear antigen 2 and the survival motor neuron protein in transactivation of the viral LMP1 promoter.
    Voss MD; Hille A; Barth S; Spurk A; Hennrich F; Holzer D; Mueller-Lantzsch N; Kremmer E; Grässer FA
    J Virol; 2001 Dec; 75(23):11781-90. PubMed ID: 11689659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus nuclear protein 2 interacts with p300, CBP, and PCAF histone acetyltransferases in activation of the LMP1 promoter.
    Wang L; Grossman SR; Kieff E
    Proc Natl Acad Sci U S A; 2000 Jan; 97(1):430-5. PubMed ID: 10618435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the Epstein-Barr virus (EBV) latent membrane protein 1 (LMP-1) gene and promoter in Hodgkin's disease isolates: selection against EBV variants with mutations in the LMP-1 promoter ATF-1/CREB-1 binding site.
    Sandvej K; Andresen BS; Zhou XG; Gregersen N; Hamilton-Dutoit S
    Mol Pathol; 2000 Oct; 53(5):280-8. PubMed ID: 11091852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activated mouse Notch1 transactivates Epstein-Barr virus nuclear antigen 2-regulated viral promoters.
    Höfelmayr H; Strobl LJ; Stein C; Laux G; Marschall G; Bornkamm GW; Zimber-Strobl U
    J Virol; 1999 Apr; 73(4):2770-80. PubMed ID: 10074124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.
    Scala G; Quinto I; Ruocco MR; Mallardo M; Ambrosino C; Squitieri B; Tassone P; Venuta S
    J Virol; 1993 May; 67(5):2853-61. PubMed ID: 8386279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.